Bernie O'Brien Investigator Award Chair

Anthony Newall, PhD, MPH, BScAnthony_Newall

Associate Professor, UNSW Australia, School of Public Health and Community Medicine, The University of New South Wales, Sydney, NSW Australia

About the Award

The Bernie O'Brien New Investigator Award is given to an individual who has shown evidence of exceptional promise based on their emerging body of technical and scholarly work in the field of health economics and outcomes research (HEOR).

Description:

The ISPOR Bernie O'Brien New Investigator Award was established in 2004 in honor of Bernie J. O'Brien, PhD, who demonstrated a long-standing commitment to training and mentoring new scientists in the field.


 

Criteria:

The recipient of the ISPOR Bernie O'Brien New Investigator Award is selected by the O'Brien New Investigator Award Committee. The recipient shall be a member of ISPOR on the date of nomination and be nominated by an individual who has been an ISPOR member in good standing for at least 2 consecutive years prior to the date of nomination. Evidence of exceptional promise shall be assessed by evaluating the nominee's emerging body of technical and scholarly work in the fields of health economics and outcomes research. The emerging body of work may include research publications, technical reports and papers, books and book chapters, and other scholarly activities that establish the importance of the nominee's early contributions. The nominees shall be no more than 7 years from the receipt of their last degree in outcomes research or related field and no more than 10 years from their first publication in outcomes research or related field.

A candidate may only be nominated for 1 major ISPOR award in a year.


 

Selection Process:

A call-for-nominations from the membership and the award selection criteria will be are published in November-December Value & Outcomes Spotlight. The New Investigator Committee Core Group meets via teleconference in March to discuss each of the nominees and select the nominee who best meets the criteria. The nominee is then forwarded to the Board of Directors for final approval.

Nominations for the Bernie J. O'Brien New Investigator Award require a letter of support for the nominee and a current edition of the nominee's CV that should be emailed to ISPOR.


 

Nature of the Award:

The award will be known as "ISPOR Bernie J. O'Brien New Investigator Award."

The Award will be presented at the ISPOR conference or the ISPOR Europe conference each year.

The award consists of a plaque, complimentary conference registration, an unrestricted research grant of US$5,000.00 and up to US$1,500.00 for travel expenses.

Timeline and Procedures: Following is the selection process timeline:

November/December:
A call-for-nominations is published in Value & Outcomes Spotlight, December 15 issue.

January:
An email message is sent to all Award Committee members requesting nominees who have advanced in the field.
An email message will be sent to all ISPOR membership soliciting nominations.

February:
A second email message is sent to all ISPOR membership reminding them of the February 15 deadline for the nominations.

March:
The New Investigator Award Committee Core Group meets via teleconference to discuss and evaluate nominations.
The awardee, is sent to the Board of Directors for final approval. The Chair of the Award Committee informs the recipient. A letter from ISPOR President is sent to the recipient informing them of their selection and inviting them to attend the ISPOR conference or ISPOR Europe conference to receive their award.

Nominations for the Bernie J. O'Brien New Investigator Award require a letter of support for the nominee and a current edition of the nominee's CV that should be emailed to ISPOR.


 

Nominate a Candidate

Nominations for the Bernie J. O'Brien New Investigator Award require a letter of support for the nominee and a current edition of the nominee's CV that should be emailed to ISPOR.

 

Recipients of the Bernie O'Brien New Investigator Award

Rose_Sherri

Associate Professor, Department of Health Care Policy,
Harvard Medical School,
Boston, MA, USA

2018 - Sherri Rose, PhD

Sherri Rose, PhD, is an associate professor in the Department of Health Care Policy at Harvard Medical School, where her work is centered on developing and integrating innovative statistical approaches to advance human health. Broadly, Dr. Rose's methodological research focus is nonparametric machine learning for causal inference and prediction. Within health policy, Dr. Rose works on risk adjustment, comparative effectiveness research, and health program impact evaluation. She also co-leads the Health Policy Data Science Lab at Harvard where she directs projects in computational health economics and clinical informatics. Dr. Rose coauthored the first book on machine learning for causal inference, and her recent honors include an NIH Director's New Innovator Award to develop robust estimators for generalizability. Her research has been featured in The New York Times, USA Today, Slate, and The Boston Globe. Dr. Rose received her PhD in Biostatistics from UC Berkeley before completing an NSF Mathematical Sciences Postdoctoral Research Fellowship at Johns Hopkins University.

Chambers_James

Assistant Professor, Tufts Medical Center,
Boston, MA, USA

2017 - James D. Chambers, PhD, MPharm, MSc

James D. Chambers, PhD, MPharm, MSc, is an investigator at the Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, and an assistant professor of medicine at Tufts University in Boston, MA. James received his MPharm degree from Queens University in Belfast and previously worked as a pharmacist in the UK and Ireland. He also obtained an MSc from the University of York and PhD from Brunel University. James' research interests include examining the factors that influence coverage policy for medical technology, pharmaceutical innovation, and the use and potential value of cost-effectiveness analysis in the US health care system.

Anthony_Newall (1)

Associate Professor in Health Economics, The School of Public Health and Community Medicine, The University of New South Wales (UNSW), Australia

2016 - Dr. Newall, MPH, PhD

Dr. Newall is an Associate Professor in Health Economics at The School of Public Health and Community Medicine, UNSW Australia. He is also an Honorary Fellow at the Australian National Centre for Immunisation Research and Surveillance. He completed his MPH (Hons) and PhD at the University of Sydney on the cost-effectiveness of vaccination programs.

His main research area is the economic evaluation of infectious disease prevention strategies, as well as the statistical and epidemiological analyses that inform these evaluations. He has over 40 peer-reviewed publications on a range of vaccine preventable diseases, including the epidemiology and cost-effectiveness of prevention strategies for influenza (seasonal and pandemic), pneumococcal disease, rotavirus, and human papillomavirus.

He has been appointed to the World Health Organization Roster of Experts in the area of Health Economics and has been a visiting scholar at the National Institutes of Health. He has received several awards for his research and public health impact, including the prestigious Aileen Plant Memorial Prize and the Dean's Rising Star Award from the Faculty of Medicine, UNSW.

Anupam-Jena

Assistant Professor, Harvard Health Care Policy, Harvard Medical School, Boston, MA, USA

2015 - Anupam B. Jena, MD, PhD

Dr. Jena is an Assistant Professor of health care policy and medicine at Harvard Medical School and an internist at Massachusetts General Hospital. Dr. Jena is also a Faculty Research Fellow at the National Bureau of Economic Research. Dr. Jena's research involves several areas of health economics and policy including the economics of medical innovation and cost-effectiveness, the economics of physician behavior, medical malpractice, and productivity in health care. Dr. Jena graduated Phi Beta Kappa from the Massachusetts Institute of Technology and received his MD and PhD in Economics from the University of Chicago. He completed his residency in internal medicine at Massachusetts General Hospital. He is a recipient of the 2007 Eugene Garfield award from Research America for the best paper on the economic impact of medical technology. In 2013, he was the recipient of the NIH Director's Early Independence Award, a 5-year award given to 10-15 junior scientists nationally who show exceptional promise to conduct cross-cutting biomedical and behavioral science research.

Carlson_Josh2014

Assistant Professor, Pharmaceutical Outcomes Research and Policy Program, University of Washington

 

2014 - Josh J. Carlson, MPH, PhD

Dr. Carlson is an Assistant Professor in the Pharmaceutical Outcomes Research and Policy Program at the University of Washington and an affiliate faculty member at the Fred Hutchinson Cancer Research Center.  He graduated with his PhD from the Institute for Public Health Genetics in the School of Public Health and Community Medicine at the University of Washington in 2007 and conducted his postdoctoral training in pharmacoeconomics at the University of Washington from 2007-2009. Dr. Carlson's current research interests and work to date has primarily focused on the intersection of three areas: 1) genomics and emerging technologies in the field of personalized medicine, 2) uncertainty both in our decision-making processes and as the concept applies to the application of medical technologies in "real world" settings (i.e. outside of clinical trials) including comparative effectiveness research, and 3) economic and policy options to address these uncertainties as we seek to improve our healthcare system and the health of our population.

2013

Jennifer M. Polinski, ScD, MPH, MS

2012

Joanne LaFleur, PharmD, MSPH

2011

Lesley Tilson, PhD

2010

Jalpa A. Doshi, PhD

2009

Anirban Basu, PhD

2008

Patrick W. Sullivan, PhD

2007

Todd A. Lee, PharmD, PhD

2006

Dr. John F P Bridges

2005

Shelby D. Reed, PhD, RPh

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×